Simplified Quantification Method for in Vivo SPECT/CT Imaging of Asialoglycoprotein Receptor with 99Mtc-P(vla-co-vni) to Assess and Stage Hepatic Fibrosis in Mice

Deliang Zhang,Zhide Guo,Pu Zhang,Yesen Li,Xinhui Su,Linyi You,Mengna Gao,Chang Liu,Hua Wu,Xianzhong Zhang

DOI: https://doi.org/10.1038/srep25377

IF: 4.6

2016-01-01

Scientific Reports

Abstract:The goal of this study is to develop a noninvasive method of SPECT imaging to quantify and stage liver fibrosis with an Asialoglycoprotein receptor (ASGP-R) targeting tracer— 99m Tc- p (VLA-co-VNI). ASGP-Rs are well known to specifically express in the mammalian liver. Here, we demonstrated ASGP-R expression decreased in carbon tetrachloride (CCl 4 )-induced mouse model. ASGP-R expression correlated with liver fibrosis progression. ASGP-R could be a useful marker in the stage of liver fibrosis. Liver uptake value (LUV) derived by SPECT imaging was used to assess liver fibrosis in the CCl 4 -induced mouse model. LUV = [radioactivity (liver uptake)/radioactivity (injected)] × 100/liver volume. The LUV decreased along with the disease progression. The relationships between LUV and liver hydroxyproline (i.e. collagen), as well as Sirius Red were established and verified. A strong negative linear correlation was found between LUV and hydroxyproline levels (r = −0.83) as well as LUV and Sirius Red quantification (r = −0.83). In conclusion, SPECT imaging with 99m Tc- p (VLA-co-VNI) is useful in evaluating and staging liver fibrosis in vivo .